Catalog Number 306595 |
Device Problem
Patient-Device Incompatibility (2682)
|
Patient Problems
Edema (1820); Rash (2033); Dizziness (2194); Discomfort (2330)
|
Event Date 11/22/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Event Description
|
It was reported that when the "filled solution of flush was pushed to 2 - 3ml marking" on the bd posiflush¿ normal saline syringe, the patient "felt dizzy and uncomfortable", and "developed throat edema and rash" after injecting.It was also reported that the patient "felt normal after being injected with 10mg of dexamethasone for 1 hour".
|
|
Event Description
|
It was reported that when the "filled solution of flush was pushed to 2 - 3ml marking" on the bd posiflush¿ normal saline syringe, the patient "felt dizzy and uncomfortable", and "developed throat edema and rash" after injecting.It was also reported that the patient "felt normal after being injected with 10mg of dexamethasone for 1 hour".
|
|
Manufacturer Narrative
|
Investigation summary: two (2) samples were received for evaluation.They are in the sealed flow wrap, they have the plunger rod-rubber stopper, the tip cap and saline solution.The barrel labels confirm the lot# 8019839.Controls in place, at the manufacturing site: bioburden tested on a weekly basis.An overkill sterilization process is used.Environmental testing within the filling area is done on a biweekly basis.The sterilization process is challenged and re-qualified annually.The solution is filtered twice before it is filled in syringes (note: once when transferring to the hold tank and again at the fill machine).Endotoxin testing is performed on each batch.Fill room operators are trained and qualified on gowning for the fill room environment on an annual basis.Weekly bioburden testing on the components used to assemble the syringes.Continuous online monitoring of the wfi water quality (note: this is for toc and conductivity, not microbial - weekly bioburden and endotoxin testing of the usp purified water and wfi systems.Weekly endotoxin testing of the pure steam system.Each sterilizer is thoroughly validated before used for posiflush sterilization.Additional lab analysis was completed on the returned samples and both sample passed with no issues found.Root cause for the reported issue is undetermined.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.A device history record review was completed with zero defects found.No quality notifications were written for this batch, nor for the associated assembly batches.
|
|
Search Alerts/Recalls
|